Overview The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression Status: Not yet recruiting Trial end date: 2024-10-15 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of Ammoxetine hydrochloride enteric-coated tablets in subjects with depression. Phase: Phase 2 Details Lead Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.